US Stock MarketDetailed Quotes

Wave Life Sciences (WVE)

Watchlist
  • 7.290
  • +0.110+1.53%
Close May 6 16:00 ET
  • 7.450
  • +0.160+2.19%
Pre 04:07 ET
1.40BMarket Cap-6.94P/E (TTM)

Wave Life Sciences (WVE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
5.53%-59.55M
-24.15%-187.49M
22.62%-33.78M
3.90%-44.67M
-67.51%-46.01M
-88.56%-63.04M
-677.24%-151.03M
-31.32%-43.65M
-34.89%-46.48M
26.27%-27.47M
Net income from continuing operations
44.35%-26.09M
-110.68%-204.38M
-281.79%-53.18M
12.83%-53.85M
-53.29%-50.47M
-48.55%-46.88M
-68.67%-97.01M
279.95%29.25M
-951.90%-61.78M
-56.00%-32.92M
Depreciation and amortization
6.52%2.31M
2.18%8.85M
4.92%2.26M
3.34%2.23M
1.10%2.2M
-0.60%2.16M
-5.90%8.66M
-1.19%2.16M
-4.68%2.16M
-6.46%2.17M
Change In working capital
-92.60%-44.83M
77.66%-16.94M
112.50%9.79M
-94.97%484K
-1,848.02%-3.94M
-235.80%-23.28M
-497.37%-75.82M
-263.90%-78.3M
120.78%9.61M
99.03%-202K
-Change in receivables
-10.27%1.28M
-99.26%146K
713.50%8.72M
-749.84%-8.38M
-25.35%-1.62M
-93.26%1.42M
193.26%19.66M
89.90%-1.42M
118.43%1.29M
---1.29M
-Change in prepaid assets
-425.91%-4.83M
212.23%1.15M
-269.46%-1.74M
-97.02%47K
235.12%1.36M
220.78%1.48M
118.59%368K
142.87%1.03M
5.14%1.58M
-560.27%-1.01M
-Change in payables and accrued expense
33.21%-10.23M
-35.86%4.92M
8.02%11.23M
318.23%3.52M
-45.99%5.49M
-35.88%-15.32M
271.10%7.67M
136.56%10.4M
-159.79%-1.61M
235.97%10.16M
-Change in other current assets
-736.44%-751K
233.77%4.31M
89.27%-452K
102.89%4.85M
-3,216.67%-199K
108.46%118K
-60.45%-3.23M
-4,730.77%-4.21M
778.31%2.39M
98.95%-6K
-Change in other current liabilities
-13.63%-2.05M
-13.76%-7.64M
-13.59%-2.01M
-13.72%-1.94M
-13.80%-1.89M
-13.95%-1.81M
-18.08%-6.71M
-14.01%-1.77M
-1.31%-1.71M
-14.26%-1.66M
-Change in other working capital
-207.86%-28.25M
78.81%-19.83M
92.75%-5.97M
-68.84%2.39M
-10.62%-7.08M
26.82%-9.18M
-272.27%-93.59M
-932.82%-82.33M
118.26%7.68M
71.04%-6.4M
Cash from discontinued investing activities
Operating cash flow
5.53%-59.55M
-24.15%-187.49M
22.62%-33.78M
3.90%-44.67M
-67.51%-46.01M
-88.56%-63.04M
-677.24%-151.03M
-31.32%-43.65M
-34.89%-46.48M
26.27%-27.47M
Investing cash flow
Cash flow from continuing investing activities
-165.45%-438K
23.45%-718K
101.16%1K
35.25%-248K
-488.46%-306K
60.43%-165K
15.87%-938K
75.84%-86K
-93.43%-383K
27.78%-52K
Net PPE purchase and sale
-165.45%-438K
23.45%-718K
101.16%1K
35.25%-248K
-488.46%-306K
60.43%-165K
15.87%-938K
75.84%-86K
-93.43%-383K
27.78%-52K
Net investment purchase and sale
----
----
----
----
----
----
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
-165.45%-438K
23.45%-718K
101.16%1K
35.25%-248K
-488.46%-306K
60.43%-165K
15.87%-938K
75.84%-86K
-93.43%-383K
27.78%-52K
Financing cash flow
Cash flow from continuing financing activities
-39.18%2.53M
92.30%488.24M
1,156.95%439.7M
-83.95%32.69M
1,690.66%11.69M
-71.36%4.16M
91.57%253.89M
-62.77%34.98M
12,100.36%203.75M
-64.68%653K
Net common stock issuance
--0
100.06%472.49M
1,204.94%429.91M
-83.98%30.21M
1,929.07%11.1M
-91.01%1.26M
79.91%236.18M
-64.79%32.95M
14,234.80%188.65M
-68.99%547K
Proceeds from stock option exercised by employees
-12.65%2.53M
-11.09%15.75M
380.45%9.78M
-83.58%2.48M
460.38%594K
512.92%2.89M
1,309.23%17.71M
424.74%2.04M
4,165.54%15.1M
24.71%106K
Cash from discontinued financing activities
Financing cash flow
-39.18%2.53M
92.30%488.24M
1,156.95%439.7M
-83.95%32.69M
1,690.66%11.69M
-71.36%4.16M
91.57%253.89M
-62.77%34.98M
12,100.36%203.75M
-64.68%653K
Net cash flow
Beginning cash position
98.10%605.87M
49.88%305.84M
-36.44%200.01M
34.61%212.27M
33.69%246.85M
49.88%305.84M
121.42%204.05M
119.11%314.69M
-10.73%157.69M
-13.00%184.64M
Current changes in cash
2.68%-57.46M
194.35%300.02M
4,737.50%405.92M
-107.79%-12.22M
-28.88%-34.63M
-205.34%-59.05M
-8.98%101.93M
-114.50%-8.75M
575.63%156.89M
24.28%-26.87M
Effect of exchange rate changes
-106.90%-4K
108.70%12K
41.75%-60K
-124.17%-29K
153.09%43K
178.38%58K
-45.26%-138K
-277.59%-103K
475.00%120K
19.00%-81K
End cash Position
122.16%548.41M
98.10%605.87M
98.10%605.87M
-36.44%200.01M
34.61%212.27M
33.69%246.85M
49.88%305.84M
49.88%305.84M
119.11%314.69M
-10.73%157.69M
Free cash flow
5.08%-59.99M
-23.85%-188.21M
22.77%-33.78M
4.15%-44.91M
-68.31%-46.32M
-86.72%-63.2M
-639.63%-151.96M
-30.18%-43.73M
-35.22%-46.86M
26.28%-27.52M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 5.53%-59.55M-24.15%-187.49M22.62%-33.78M3.90%-44.67M-67.51%-46.01M-88.56%-63.04M-677.24%-151.03M-31.32%-43.65M-34.89%-46.48M26.27%-27.47M
Net income from continuing operations 44.35%-26.09M-110.68%-204.38M-281.79%-53.18M12.83%-53.85M-53.29%-50.47M-48.55%-46.88M-68.67%-97.01M279.95%29.25M-951.90%-61.78M-56.00%-32.92M
Depreciation and amortization 6.52%2.31M2.18%8.85M4.92%2.26M3.34%2.23M1.10%2.2M-0.60%2.16M-5.90%8.66M-1.19%2.16M-4.68%2.16M-6.46%2.17M
Change In working capital -92.60%-44.83M77.66%-16.94M112.50%9.79M-94.97%484K-1,848.02%-3.94M-235.80%-23.28M-497.37%-75.82M-263.90%-78.3M120.78%9.61M99.03%-202K
-Change in receivables -10.27%1.28M-99.26%146K713.50%8.72M-749.84%-8.38M-25.35%-1.62M-93.26%1.42M193.26%19.66M89.90%-1.42M118.43%1.29M---1.29M
-Change in prepaid assets -425.91%-4.83M212.23%1.15M-269.46%-1.74M-97.02%47K235.12%1.36M220.78%1.48M118.59%368K142.87%1.03M5.14%1.58M-560.27%-1.01M
-Change in payables and accrued expense 33.21%-10.23M-35.86%4.92M8.02%11.23M318.23%3.52M-45.99%5.49M-35.88%-15.32M271.10%7.67M136.56%10.4M-159.79%-1.61M235.97%10.16M
-Change in other current assets -736.44%-751K233.77%4.31M89.27%-452K102.89%4.85M-3,216.67%-199K108.46%118K-60.45%-3.23M-4,730.77%-4.21M778.31%2.39M98.95%-6K
-Change in other current liabilities -13.63%-2.05M-13.76%-7.64M-13.59%-2.01M-13.72%-1.94M-13.80%-1.89M-13.95%-1.81M-18.08%-6.71M-14.01%-1.77M-1.31%-1.71M-14.26%-1.66M
-Change in other working capital -207.86%-28.25M78.81%-19.83M92.75%-5.97M-68.84%2.39M-10.62%-7.08M26.82%-9.18M-272.27%-93.59M-932.82%-82.33M118.26%7.68M71.04%-6.4M
Cash from discontinued investing activities
Operating cash flow 5.53%-59.55M-24.15%-187.49M22.62%-33.78M3.90%-44.67M-67.51%-46.01M-88.56%-63.04M-677.24%-151.03M-31.32%-43.65M-34.89%-46.48M26.27%-27.47M
Investing cash flow
Cash flow from continuing investing activities -165.45%-438K23.45%-718K101.16%1K35.25%-248K-488.46%-306K60.43%-165K15.87%-938K75.84%-86K-93.43%-383K27.78%-52K
Net PPE purchase and sale -165.45%-438K23.45%-718K101.16%1K35.25%-248K-488.46%-306K60.43%-165K15.87%-938K75.84%-86K-93.43%-383K27.78%-52K
Net investment purchase and sale --------------------------0------------
Cash from discontinued investing activities
Investing cash flow -165.45%-438K23.45%-718K101.16%1K35.25%-248K-488.46%-306K60.43%-165K15.87%-938K75.84%-86K-93.43%-383K27.78%-52K
Financing cash flow
Cash flow from continuing financing activities -39.18%2.53M92.30%488.24M1,156.95%439.7M-83.95%32.69M1,690.66%11.69M-71.36%4.16M91.57%253.89M-62.77%34.98M12,100.36%203.75M-64.68%653K
Net common stock issuance --0100.06%472.49M1,204.94%429.91M-83.98%30.21M1,929.07%11.1M-91.01%1.26M79.91%236.18M-64.79%32.95M14,234.80%188.65M-68.99%547K
Proceeds from stock option exercised by employees -12.65%2.53M-11.09%15.75M380.45%9.78M-83.58%2.48M460.38%594K512.92%2.89M1,309.23%17.71M424.74%2.04M4,165.54%15.1M24.71%106K
Cash from discontinued financing activities
Financing cash flow -39.18%2.53M92.30%488.24M1,156.95%439.7M-83.95%32.69M1,690.66%11.69M-71.36%4.16M91.57%253.89M-62.77%34.98M12,100.36%203.75M-64.68%653K
Net cash flow
Beginning cash position 98.10%605.87M49.88%305.84M-36.44%200.01M34.61%212.27M33.69%246.85M49.88%305.84M121.42%204.05M119.11%314.69M-10.73%157.69M-13.00%184.64M
Current changes in cash 2.68%-57.46M194.35%300.02M4,737.50%405.92M-107.79%-12.22M-28.88%-34.63M-205.34%-59.05M-8.98%101.93M-114.50%-8.75M575.63%156.89M24.28%-26.87M
Effect of exchange rate changes -106.90%-4K108.70%12K41.75%-60K-124.17%-29K153.09%43K178.38%58K-45.26%-138K-277.59%-103K475.00%120K19.00%-81K
End cash Position 122.16%548.41M98.10%605.87M98.10%605.87M-36.44%200.01M34.61%212.27M33.69%246.85M49.88%305.84M49.88%305.84M119.11%314.69M-10.73%157.69M
Free cash flow 5.08%-59.99M-23.85%-188.21M22.77%-33.78M4.15%-44.91M-68.31%-46.32M-86.72%-63.2M-639.63%-151.96M-30.18%-43.73M-35.22%-46.86M26.28%-27.52M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More